Literature DB >> 5944058

Hypovolemic shock of hypoproteinemia. Report of a case treated with metaraminol infusion in a child.

T Sreedharan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5944058     DOI: 10.1007/bf02811506

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  10 in total

1.  Septic shock.

Authors:  R R BRADHAM; G B BRADHAM
Journal:  J S C Med Assoc       Date:  1962-11

2.  Relentless shock.

Authors:  M BACKER; M A DEAN; E P IASIELLO
Journal:  JAMA       Date:  1960-11-05       Impact factor: 56.272

3.  CLINICAL OBSERVATIONS ON THE EFFICACY OF METARAMINOL IN THE TREATMENT OF SHOCK.

Authors:  R E FREMONT; B JAGENDORF
Journal:  Curr Ther Res Clin Exp       Date:  1964-01

4.  THERAPY OF REFRACTORY SHOCK.

Authors:  A R MANSBERGER; R M OLLODART; S ATTAR; R A COWLEY; R W BUXTON
Journal:  Ann Surg       Date:  1965-06       Impact factor: 12.969

5.  Methadone poisoning in a child.

Authors:  S G RATCLIFFE
Journal:  Br Med J       Date:  1963-04-20

6.  Symposium on medical emergencies. Shock.

Authors:  R E CARTER
Journal:  Pediatr Clin North Am       Date:  1962-02       Impact factor: 3.278

7.  Current concepts on the management of shock.

Authors:  M H WEIL
Journal:  Circulation       Date:  1957-12       Impact factor: 29.690

8.  The use of aramine in clinical shock.

Authors:  A FANKHAUSER; S I FISHMAN; P F MADONIA; G SCHWARTZ; G H STECHEL; H TURKOWITZ
Journal:  Circulation       Date:  1956-06       Impact factor: 29.690

9.  Ventricular function. V. The circulatory effects of aramine; mechanism of action of vasopressor drugs in cardiogenic shock.

Authors:  S J SARNOFF; R B CASE; E BERGLUND; L C SARNOFF
Journal:  Circulation       Date:  1954-07       Impact factor: 29.690

10.  Clinical studies on a vasopressor agent: metaraminol (aramine). I. Observations in normotensive subjects.

Authors:  M H WEIL; W W SPINK
Journal:  Am J Med Sci       Date:  1955-06       Impact factor: 2.378

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.